NS-220
NS-220 is an orally active PPARα agonist with high subtype selectivity, with EC50 values of 1.9x10-8 M, 9.6x10-6 M and >10-4 M for PPARα, PPAR γ and PPARδ, respectively. NS-220 is used in the research for hyperlipidemia or metabolic disorders in type-2 diabetes[1].
Product Specifications
CAS Number
377731-45-8
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ns-220.html
Smiles
O=C([C@]1(C)OC[C@H](CCCCC2=C(C)OC(C3=CC=C(C)C=C3)=N2)CO1)O
Molecular Formula
C21H27NO5
Molecular Weight
373.44
References & Citations
[1]Kenji Kuwabara, et al. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2- (4-methylphenyl) -4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KK-Ay mice. J Pharmacol Exp Ther. 2004 Jun;309 (3) :970-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
PPARα; PPARγ; PPARδ
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog